X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE JUBILANT LIFE SCIENCES TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 33.1 23.9 138.4% View Chart
P/BV x 6.1 4.9 124.2% View Chart
Dividend Yield % 0.5 0.4 128.7%  

Financials

 TTK HEALTHCARE   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
TTK HEALTHCARE/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs663187 355.1%   
Low Rs39965 612.9%   
Sales per share (Unadj.) Rs535.6364.3 147.0%  
Earnings per share (Unadj.) Rs15.96.8 232.9%  
Cash flow per share (Unadj.) Rs20.024.5 81.7%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Dividend yield (eoy) %0.82.4 31.6%  
Book value per share (Unadj.) Rs137.6164.9 83.5%  
Shares outstanding (eoy) m7.77159.28 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.00.3 286.9%   
Avg P/E ratio x33.318.4 181.1%  
P/CF ratio (eoy) x26.55.1 516.0%  
Price / Book Value ratio x3.90.8 505.4%  
Dividend payout %25.143.8 57.2%   
Avg Mkt Cap Rs m4,12720,061 20.6%   
No. of employees `0001.76.2 27.6%   
Total wages/salary Rs m60711,052 5.5%   
Avg. sales/employee Rs Th2,436.79,383.0 26.0%   
Avg. wages/employee Rs Th355.21,786.9 19.9%   
Avg. net profit/employee Rs Th72.5176.3 41.1%   
INCOME DATA
Net Sales Rs m4,16258,034 7.2%  
Other income Rs m61191 32.1%   
Total revenues Rs m4,22358,224 7.3%   
Gross profit Rs m1975,786 3.4%  
Depreciation Rs m322,812 1.1%   
Interest Rs m303,237 0.9%   
Profit before tax Rs m197-72 -272.8%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m73696 10.5%   
Profit after tax Rs m1241,090 11.4%  
Gross profit margin %4.710.0 47.5%  
Effective tax rate %37.0-965.9 -3.8%   
Net profit margin %3.01.9 158.4%  
BALANCE SHEET DATA
Current assets Rs m1,62929,280 5.6%   
Current liabilities Rs m1,05838,912 2.7%   
Net working cap to sales %13.7-16.6 -82.7%  
Current ratio x1.50.8 204.6%  
Inventory Days Days3084 35.3%  
Debtors Days Days3451 66.3%  
Net fixed assets Rs m55655,712 1.0%   
Share capital Rs m78155 50.3%   
"Free" reserves Rs m87820,968 4.2%   
Net worth Rs m1,06926,265 4.1%   
Long term debt Rs m15917,169 0.9%   
Total assets Rs m2,39988,606 2.7%  
Interest coverage x7.61.0 775.1%   
Debt to equity ratio x0.10.7 22.7%  
Sales to assets ratio x1.70.7 264.8%   
Return on assets %6.44.9 131.2%  
Return on equity %11.64.2 279.1%  
Return on capital %18.511.6 159.5%  
Exports to sales %0.837.8 2.1%   
Imports to sales %1.416.5 8.5%   
Exports (fob) Rs m3321,933 0.2%   
Imports (cif) Rs m589,567 0.6%   
Fx inflow Rs m3322,004 0.1%   
Fx outflow Rs m6311,749 0.5%   
Net fx Rs m-3010,255 -0.3%   
CASH FLOW
From Operations Rs m1278,026 1.6%  
From Investments Rs m-146-1,744 8.4%  
From Financial Activity Rs m22-4,447 -0.5%  
Net Cashflow Rs m31,834 0.1%  

Share Holding

Indian Promoters % 65.4 45.6 143.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 3.7 8.7 42.5%  
FIIs % 5.2 21.2 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.1 122.3%  
Shareholders   12,723 23,815 53.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   NATCO PHARMA  PLETHICO PHARMA  WOCKHARDT LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 16, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS